Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Light

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|September 12, 2018
Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosisImadul Islam, Shendong Yuan, Christopher W West, et al.
Journal of Medicinal Chemistry|June 1, 2007
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitorsBin Ye, Damian O Arnaiz, Yuo-Ling Chou, et al.
Nature|July 22, 2011
An integrated semiconductor device enabling non-optical genome sequencingJonathan M Rothberg, Wolfgang Hinz, Todd M Rearick, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|September 12, 2018
Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosisImadul Islam, Shendong Yuan, Christopher W West, et al.
Journal of Medicinal Chemistry|June 1, 2007
Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitorsBin Ye, Damian O Arnaiz, Yuo-Ling Chou, et al.
Nature|July 22, 2011
An integrated semiconductor device enabling non-optical genome sequencingJonathan M Rothberg, Wolfgang Hinz, Todd M Rearick, et al.
Pageof 3